Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus Peter H. JonesKenneth CusiC. Stolzenbach Original Research Article 17 August 2012 Pages: 73 - 84
Predictors of Annual Pharmaceutical Costs in Australia for Community-Based Individuals with, or at Risk of, Cardiovascular Disease Zanfina AdemiDanny LiewChristopher M. Reid Original Research Article 17 August 2012 Pages: 85 - 94
Preservation of Bioavailability of Ingredients and Lack of Drug-Drug Interactions in a Novel Five-Ingredient Polypill (Polycap™) Anil PatelTarang ShahBhaswat S. Chakraborty Original Research Article 17 August 2012 Pages: 95 - 103
Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia Megan N. WillsonJoshua J. NeumillerTracy L. Skaer Short Communication 17 August 2012 Pages: 105 - 108
Extent of Control of Cardiovascular Risk Factors and Adherence to Recommended Therapies in US Multiethnic Adults with Coronary Heart Disease Dusko VulicBrian T. LeeNathan D. Wong Short Communication 17 August 2012 Pages: 109 - 114
Heterogeneity of Efficacy and Safety of Antiplatelet Therapy in Cardiovascular and Cerebrovascular Disease James M. Gebel Review Article 17 August 2012 Pages: 115 - 124
Low-Dose Aspirin Therapy for Cardiovascular Prevention Johan HerlitzPeter P. TóthJørgen Næsdal Review Article 17 August 2012 Pages: 125 - 141